학술논문
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer (Nature Communications, (2022), 13, 1, (5258), 10.1038/s41467-022-32828-6)
Document Type
Erratum
Author
Palafox, M.; Monserrat, L.; Òdena, A.; Sánchez-Guixé, M.; Rodríguez, O.; Guzmán, M.; Grueso, J.; Serra, V.; Bellet, M.; Oliveira, M.; Capelán, M.; Azaro, A.; Saura, C.; Villacampa, G.; Viaplana, C.; Dienstmann, R.; Gonzalez-Perez, A.; Lopez-Bigas, N.; Brasó-Maristany, F.; Prat, A.; Ibrahimi, N.; Michiels, S.; Kannan, S.; Verma, C.S.; Mina, L.; García-Sanz, A.; Herrera-Abreu, M.T.; Turner, N.C.; Bruna, A.; Hernández, J.; Su, F.; Lin, K.; Clarke, R.B.; Caldas, C.; Arribas, J.; Nuciforo, P.; Scaltriti, M.; Arnedos, M.
Source
In: Nature Communications . (Nature Communications, December 2022, 13(1))
Subject
Language
English
ISSN
20411723